GUMDROP : E7080-G000-205 A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

Created by Nancy Dawson, last modified on Apr 28, 2013

Description:

This is an open-label, multicenter, Phase 1b/2 study of E7080 alone and in combination with everolimus in subjects with unresectable advanced or metastatic renal cell carcinoma following one prior VEGF-targeted treatment.

Link:

http://www.clinicaltrials.gov/ct2/show/study/NCT01136733

Site:

Georgetown University Hospital

Principal Investigator:

Dr. Nancy A. Dawson